Managing side effects associated with IL-2 therapy.
Hynes
M
M
The University of Chicago Hospitals, IL.
Bournes
L
L
Brich
A
A
Cupernall
G
G
Hanzelin
J
J
Ramming
K
K
Pitler
L R
LR
D002292:Carcinoma, Renal Cell / Q000628:therapy; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D009859:Oncology Nursing
D007376:Interleukin-2